Development and pilot testing of a gender-sensitive primary care intervention for patients with chronic non-cancer pain receiving long-term opioid therapy

Development and pilot testing of a gender-sensitive primary care intervention for patients with chronic non-cancer pain receiving long-term opioid therapy - GESCO

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00029980

Enrollment

Registered

2022-09-09

Start date

2023-10-31

Completion date

Unknown

Last updated

2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic non-cancer pain

Interventions

Group 1: The pilot study examines the feasibility of an educational training for general practitioners, which enables them to adequately consider psycho-social, cultural, gender-specific, and role-spe

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1) chronic non-cancer pain 2) opioid-therapy since at least 3 months

Exclusion criteria

Exclusion criteria: 1) clinical relevant malignant primary disease 2) substitutional therapy 3) insufficient language skills for participation

Design outcomes

Primary

Measure	Time frame
Feasibility (of implementing the intervention and of the trial methods)	—

Secondary

Measure	Time frame
Patient-centred clinical outcomes: 1) impact of pain on everyday life (PDI) 2) subjective pain perception (10-point pain scale) 3) pain medication 4) adverse effects of pain medication 5) risk for opioid medication misuse (PMQ) 6) satisfaction with information about medication (SIMS) 7) Perceived stigma due to chronic pain (ISCP) 8) optimism-pessimism (SOP2) 9) mental health (PHQ-9) 10) pain medication (DDD)	—

Measure

Time frame

Patient-centred clinical outcomes: 1) impact of pain on everyday life (PDI) 2) subjective pain perception (10-point pain scale) 3) pain medication 4) adverse effects of pain medication 5) risk for opioid medication misuse (PMQ) 6) satisfaction with information about medication (SIMS) 7) Perceived stigma due to chronic pain (ISCP) 8) optimism-pessimism (SOP2) 9) mental health (PHQ-9) 10) pain medication (DDD)

—

Countries

Germany

Contacts

Public ContactAlexandra Schmidt

Lehrstuhl für Allgemeinmedizin II und Patientenorientierung in der Primärversorgung, Institut für Allgemeinmedizin und Ambulante Gesundheitsversorgung (IAMAG), Universität Witten/Herdecke

alexandra.schmidt@uni-wh.de02302 926 7376

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Jun 11, 2026